The Pharma Letter1h
UCB closes portfolio divestment and focuses on new launch in China
Belgium’s largest drugmaker UCB on Friday announced the successful closing of the sale, divestment and license of its mature ...
The Pharma Letter21h
Beijing’s Allink secures $42 million in series A
Allink Biotherapeutics, a Chinese startup specializing in bispecific antibodies and antibody-drug conjugates, raises $42 ...
The Pharma Letter21h
More positive data for Shanghai’s Minghui
Minghui Pharmaceutical announces successful Phase III trial of MH004 for atopic dermatitis, achieving significant skin ...
The Pharma Letter20h
Enhertu added to China's health insurance plan
AstraZeneca and Daiichi Sankyo’s breast cancer drug Enhertu to join China’s state health insurance in 2025, enhancing ...
The Pharma Letter21h
Innovent updates on Sintbilo in China
China’s Innovent Biologics has announced that the updated 2024 National Reimbursement Drug List (NRDL) now includes Sintbilo ...
The Pharma Letter21h
Denmark to permanently legalize medical cannabis
The Danish Ministry of Interior and Health has announced that the political parties have decided to permanently legalize ...